Movement, so I bt back some of the ones I sold months ago. I can't see how this won't be a goer. The mesh out there is a failure and class actions should see Pharma pay up big I hope.
MKT The ASX can overlook its Telecomm small-caps. Here’s one diversified brand with an international footprint